Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...
Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.
The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.
For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the ...
CMS launches Medicare GLP-1 Bridge to offer select beneficiaries fixed-cost access to GLP-1 drugs from July 2026 through 2027.
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results